These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38883639)

  • 1. Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan.
    Omori T; Hanafusa M; Kondo N; Miyazaki Y; Okada S; Fujiwara T; Kuramochi J
    J Thorac Dis; 2024 May; 16(5):3170-3180. PubMed ID: 38883639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
    Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Madeddu G; De Vito A; Gardenal N; Valentinotti R; Tofanelli M; Borsetto D; Lechien JR; Polesel J; De Riu G; Vaira LA
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1273-1281. PubMed ID: 35286777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
    Smith H; Mahon A; Moss A; Rao S
    J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway.
    Iversen A; Blomberg B; Haug K; Kittang B; Özgümüs T; Cox RJ; Langeland N
    Front Public Health; 2024; 12():1320059. PubMed ID: 38504678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
    Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
    Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Long Covid Symptoms in an Online Cohort Study.
    Durstenfeld MS; Peluso MJ; Peyser ND; Lin F; Knight SJ; Djibo A; Khatib R; Kitzman H; O'Brien E; Williams N; Isasi C; Kornak J; Carton TW; Olgin JE; Pletcher MJ; Marcus GM; Beatty AL
    medRxiv; 2022 Dec; ():. PubMed ID: 36523412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.
    St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL
    mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
    Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
    Kahlert CR; Strahm C; Güsewell S; Cusini A; Brucher A; Goppel S; Möller E; Möller JC; Ortner M; Ruetti M; Stocker R; Vuichard-Gysin D; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Vernazza P; Kuster SP; Kohler P;
    Clin Infect Dis; 2023 Jul; 77(2):194-202. PubMed ID: 36905145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
    PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
    Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
    Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
    Woo MS; Mayer C; Brehm TT; Andersen G; Weigel A; Löwe B; Lohse AW; Addo MM; Gerloff C; Knobloch JKM; Schulze Zur Wiesch J; Friese MA
    Brain Commun; 2023; 5(2):fcad092. PubMed ID: 37038497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.